Cargando...
Subcutaneous to Intravenous Prostacyclin Analogue Transition in Pulmonary Hypertension
INTRODUCTION: Prostacyclin analogues are FDA-approved therapies for the treatment of Pulmonary Arterial Hypertension (PAH) and can be administered by inhalational, intravenous (IV) or subcutaneous (SQ) routes. Since there is limited data to guide the transition between SQ to IV prostacyclin analogue...
Gardado en:
| Publicado en: | J Cardiovasc Pharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662283/ https://ncbi.nlm.nih.gov/pubmed/24084219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000018 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|